A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

BACKGROUND: Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. However, there are few data on the safety and efficacy of paclitaxel plus ramucirumab in patients with AGC wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Matsumoto, Hiroshi, Kawazoe, Akihito, Shimada, Kaoru, Fukuoka, Shota, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Ohtsu, Atsushi, Yoshino, Takayuki, Doi, Toshihiko, Shitara, Kohei
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793350/
https://ncbi.nlm.nih.gov/pubmed/29385993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4057-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky